Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study

OBJECTIVE: The aim of this study was to estimate the efficacy of elagolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, for the treatment of endometriosis-associated pelvic pain. METHODS: This was a phase II, randomized, placebo-controlled parallel group study conducted at 37 US centers...

Descripción completa

Detalles Bibliográficos
Autores principales: Carr, Bruce, Giudice, Linda, Dmowski, W. Paul, O'Brien, Chris, Jiang, Ping, Burke, Joshua, Jimenez, Roland, Hass, Steven, Fuldeore, Mahesh, Chwalisz, Kristof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166402/
https://www.ncbi.nlm.nih.gov/pubmed/30320043
http://dx.doi.org/10.5301/je.5000157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166402/
https://www.ncbi.nlm.nih.gov/pubmed/30320043
http://dx.doi.org/10.5301/je.5000157

Ejemplares similares